CD58 activators are a unique class of chemical compounds that interact with the cell surface protein CD58, also known as lymphocyte function-associated antigen 3 (LFA-3). This protein plays a crucial role in the immune response, enabling communication between cells in the immune system. CD58 primarily interacts with the CD2 protein on T cells, fostering cell-cell adhesion, an essential step in immune response activation. CD58 activators work by either directly or indirectly promoting the activation of CD58, leading to increased interaction with CD2.
The precise mechanisms by which CD58 activators function can vary widely, depending on the specific compound. Some CD58 activators work indirectly by modulating intracellular signaling pathways that control CD58 activation. On the other hand, some compounds like jasplakinolide, which promote actin polymerization, may indirectly propel changes in CD58's role by influencing the formation of the immunological synapse, a crucial structure in T cell activation. It's important to note that not all interactions with CD58 necessarily enhance the immune response. Some compounds might suppress immune activity by modulating CD58's interactions. For instance, cyclosporine A and rapamycin, both of which are immunosuppressants, can indirectly initiate changes in CD58-CD2 interaction by reducing T cell activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressant that suppresses calcineurin, indirectly initiating changes in CD58-CD2 interaction by reducing T cell activation | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Immunosuppressant that constrains mTOR, indirectly sparking changes in CD58's role by reducing T cell activation and proliferation | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Stimulates protein kinase C, involved in T cell signaling, potentially triggering changes in CD58-CD2 mediated cell adhesion | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Elevates intracellular calcium concentration, indirectly driving changes in CD58-CD2 interaction via T cell signaling | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases, potentially setting off changes in signal transduction pathways that might indirectly activate CD58 | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, a key enzyme in the PI3K/Akt pathway, potentially inciting changes in T-cell receptor signaling and CD58-CD2 interaction | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, possibly propelling changes in T-cell receptor signaling and CD58-CD2 interaction | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum protein kinase inhibitor, potentially inciting changes in multiple pathways involved in T cell activation and CD58-CD2 interaction | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Inhibits LCK, a protein involved in T cell receptor signaling, potentially setting off changes in the CD58-CD2 interaction | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Inhibits actin polymerization, potentially sparking changes in immunological synapse formation and CD58's role in this process | ||||||